Publication | Open Access

A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

Intellectual ImpairmentFragile X SyndromeDevelopmental DisabilityFragile X SpectrumRehabilitationCognitive TrainingMedicinePhase 1Fragile X PremutationDevelopmental Delay